Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
2,396.37
2,080.29
1,830.56
1,655.88
1,482.97
709.35
600.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,396.37
2,080.29
1,830.56
1,655.88
1,482.97
709.35
600.09
Raw Material Cost
1,603.68
1,299.64
1,229.92
1,079.11
970.12
434.81
369.26
Purchase of Finished goods
93.42
164.77
127.13
104.85
155.21
35.81
0.00
(Increase) / Decrease In Stocks
-28.37
-31.12
-63.52
-12.64
-20.29
-8.42
2.44
Employee Cost
154.75
132.33
103.13
98.62
67.93
41.98
37.21
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
-0.01
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
286.99
249.59
184.14
162.93
126.56
81.63
86.44
Total Expenditure (Excl Depreciation)
2,110.47
1,815.22
1,580.80
1,432.86
1,299.53
585.80
495.35
Operating Profit (PBDIT) excl Other Income
285.90
265.07
249.76
223.02
183.44
123.55
104.74
Other Income
22.38
4.01
7.45
5.48
12.00
8.70
3.72
Operating Profit (PBDIT)
308.28
269.08
257.21
228.50
195.44
132.25
108.46
Interest
28.54
17.81
19.37
22.32
12.66
2.99
3.56
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
279.74
251.27
237.84
206.18
182.78
129.26
104.90
Depreciation
79.12
67.07
60.39
62.93
48.06
22.83
16.85
Profit Before Tax
200.62
184.21
177.44
143.26
134.73
106.43
88.06
Tax
53.30
48.81
46.93
36.96
38.58
26.79
22.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
147.31
135.40
130.51
106.30
96.15
79.64
65.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
147.31
135.40
130.51
106.30
96.15
79.64
65.47
Share in Profit of Associates
1.90
0.98
0.18
0.96
1.55
0.41
-0.22
Minority Interest
0.00
0.00
0.00
0.00
-0.02
0.17
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
149.21
136.38
130.69
107.26
97.67
80.22
65.25
Equity Capital
11.08
11.07
11.05
11.03
11.01
10.39
10.15
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
1,322.27
1,174.38
1,036.68
904.14
794.15
398.39
276.53
Earnings per share (EPS)
26.93
24.64
23.65
19.45
17.74
15.44
12.86
Diluted Earnings per share
26.93
24.63
23.62
19.38
17.7
15.47
13.23
Operating Profit Margin (Excl OI)
11.93%
12.74%
13.64%
13.47%
12.37%
17.42%
17.45%
Gross Profit Margin
11.67%
12.08%
12.99%
12.45%
12.33%
18.22%
17.48%
PAT Margin
6.23%
6.56%
7.14%
6.48%
6.59%
11.28%
10.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 9.41% vs 4.35% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 7.86% vs 6.13% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 60.25% vs -8.05% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Rossari Biotech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,396.37
533.33
1,863.04
349.32%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,396.37
533.33
1,863.04
349.32%
Raw Material Cost
1,603.68
338.81
1,264.87
373.33%
Purchase of Finished goods
93.42
2.95
90.47
3,066.78%
(Increase) / Decrease In Stocks
-28.37
-14.15
-14.22
-100.49%
Employee Cost
154.75
24.32
130.43
536.31%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
286.99
54.17
232.82
429.80%
Total Expenditure (Excl Depreciation)
2,110.47
406.11
1,704.36
419.68%
Operating Profit (PBDIT) excl Other Income
285.90
127.22
158.68
124.73%
Other Income
22.38
24.31
-1.93
-7.94%
Operating Profit (PBDIT)
308.28
151.53
156.75
103.44%
Interest
28.54
1.07
27.47
2,567.29%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
279.74
150.46
129.28
85.92%
Depreciation
79.12
9.22
69.90
758.13%
Profit Before Tax
200.62
141.24
59.38
42.04%
Tax
53.30
32.04
21.26
66.35%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
147.31
109.21
38.10
34.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
147.31
109.21
38.10
34.89%
Share in Profit of Associates
1.90
0.00
1.90
Minority Interest
0.00
-1.00
1.00
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
149.21
108.21
41.00
37.89%
Equity Capital
11.08
22.92
-11.84
-51.66%
Face Value
2.00
2.00
0.00
Reserves
1,322.27
708.40
613.87
86.66%
Earnings per share (EPS)
26.93
0.94
25.99
2,764.89%
Diluted Earnings per share
26.93
0.95
25.98
2,734.74%
Operating Profit Margin (Excl OI)
11.93%
23.85%
0.00
-11.92%
Gross Profit Margin
11.67%
28.21%
0.00
-16.54%
PAT Margin
6.23%
20.48%
0.00
-14.25%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,396.37 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.19% vs 13.64% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 149.21 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 9.41% vs 4.35% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 285.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.86% vs 6.13% in Mar 2025
Annual - Interest
Interest 28.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 60.25% vs -8.05% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.93%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
